HOME PRODUCTS SERVICES COMPANY CONTACT FAQ

Potassium

An element that is in the alkali group of metals. It has an atomic symbol K, atomic number 19, and atomic weight 39.10. It is the chief cation in the intracellular fluid of muscle and other cells. Potassium ion is a strong electrolyte and it plays a significant role in the regulation of fluid volume and maintenance of the water-electrolyte balance.

Also Known As:

Potassium Ion Level; Ion Level, Potassium; Level, Potassium Ion

Networked: 11890 relevant articles (368 outcomes, 1057 trials/studies) for this Bio-Agent, Comments

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Pitt, Bertram: 9 articles (04/2011 - 03/2003)
2.	Parsons, C Lowell: 7 articles (02/2010 - 03/2002)
3.	Lin, Shih-Hua: 7 articles (01/2009 - 05/2002)
4.	Eckardt, Lars: 6 articles (04/2012 - 01/2002)
5.	Breithardt, Günter: 6 articles (04/2012 - 01/2002)
6.	Nattel, Stanley: 6 articles (10/2010 - 04/2006)
7.	Lee, Tsung-Ming: 6 articles (06/2009 - 02/2003)
8.	Halperin, M L: 6 articles (03/2006 - 01/2001)
9.	Ahmed, Ali: 5 articles (06/2012 - 10/2002)
10.	Appel, Lawrence J: 5 articles (01/2012 - 10/2002)

Related Diseases

1.	Hypertension (High Blood Pressure) 06/01/1972 - "Clinical efficacy of fixed combinations of saluretic agents and potassium in sustained release form for the treatment of arterial hypertension." 11/01/1998 - "Supplementation with Whey mineral and a comparable dose of potassium similarly opposed the development of experimental genetic hypertension, an effect which was associated with improved arterial dilatory properties. " 11/01/1986 - "Potassium depletion ameliorates hypertension in spontaneously hypertensive rats." 12/01/1985 - "Three months after surgery, her hypertension had improved, serum potassium levels had increased slightly, and PRA had normalized. " 01/01/2013 - "We previously showed that African Americans excreted less urinary potassium than whites, even while consuming similar diets in the Dietary Approaches to Stop Hypertension (DASH) trial. " Order ALL the reference details at left...
2.	Hypokalemia 01/01/2002 - "Since potassium depletion rarely occurs as an isolated phenomenon, associated fluid and electrolyte disorders should be corrected, and the causes of potassium loss should be sought and eliminated to complete the treatment of hypokalemia." 06/01/2000 - "Our studies demonstrated that the incidence of PA is 5.4%, and also that the plasma potassium level is not always beneficial for suspecting the presence of PA, because 28% of the patients with PA show only hypokalemia. " 03/21/1985 - "We conclude that short-term potassium supplementation that ameliorates diuretic-induced hypokalemia may induce a significant fall in blood pressure." 05/04/1999 - "Potassium supplementation may be effective in reducing blood pressure in patients with hypokalemia during diuretic therapy. " 06/15/1984 - "This study examines the efficacy of supplemental potassium in treating this hypokalemia. " Order ALL the reference details at left...
3.	Hyperkalemia 01/01/1987 - "In summary, alpha-adrenergic blockade ameliorates exercise-induced hyperkalemia in diabetic but not in control subjects, nonspecific beta-adrenergic blockade causes a greater increment in potassium when compared with exercise alone, and specific beta 1-adrenergic blockade exacerbates exercise-induced hyperkalemia in control, but not in diabetic subjects. " 11/01/2011 - "Safety and efficacy of two potassium cocktail formulations for treatment of neonatal hyperkalemia." 01/01/2010 - "Acute medical management and withholding all drugs that could cause hyperkalemia improved his serum potassium levels over 24 h and renal parameters within 5 days. " 03/01/2009 - "Management of hyperkalemia may be improved by identifying the levels of potassium that may potentially induce harm and using appropriate strategies to avert the levels that may be dangerous or life threatening." 07/01/2010 - "There was an increase in mean serum potassium of 0.39 mmol/l (P<0.01) from baseline at the end of the study period and two patients had hyperkalemia>5.5 mmol/l with dual blockade. " Order ALL the reference details at left...
4.	Myocardial Infarction 09/01/2012 - "The aim of this study was to evaluate the additional predictive value of serum potassium (SK) to Thrombolysis In Myocardial Infarction (TIMI) risk score for malignant ventricular arrhythmias (MVA) in patients within 24 hours of acute myocardial infarction (AMI). " 01/01/1990 - "The aim of the study was to evaluate changes in potassium level at 1 to 4 days in patients with acute myocardial infarction. " 01/01/1988 - "Further efforts should be made to study the effects of low plasma potassium and high plasma FFA on the myocardium in patients in the early phases of acute myocardial infarction." 01/01/1983 - "Studies on slow cardiac action potentials occurring in potassium-rich media as a simulation of the early phase of myocardial infarction. " 09/01/1950 - "The effect of different grades of myocardial infarction upon the tolerance to potassium; an experimental study in dogs." Order ALL the reference details at left...
5.	Ischemia 11/01/2010 - "The aim of this experiment was to study the effects of GBE50 on delayed rectifier potassium current (I(K)) in ventricular myocytes under normal and simulated ischemia conditions in guinea pigs. " 10/01/2007 - "In this experimental study we evaluated the pH and potassium changes of the peritoneal irrigation fluid in the early phase of mesenteric ischemia. " 07/22/2005 - "Recent studies have shown that CAPE has also a neuroprotective effects in ischemia and low potassium-induced neuronal apoptotic models. " 02/01/2005 - "The present study compared the changes of potassium currents in acutely dissociated hippocampal neurons at different intervals after ischemia. " 10/01/2000 - "A study on the electrophysiological heterogeneity of rabbit ventricular myocytes the effect of ischemia on action potentials and potassium currents." Order ALL the reference details at left...

Related Drugs and Biologics

1.	Sodium
2.	Glucose (Dextrose)
3.	Insulin (Novolin)
4.	Calcium
5.	Magnesium
6.	Adenosine Triphosphate (ATP)
7.	Creatinine
8.	Aldosterone
9.	Spironolactone (Aldactone)
10.	Urea (Carbamide)

Related Therapies and Procedures

1.	Induced Heart Arrest (Cardioplegia)
2.	Intravenous Infusions
3.	Renal Dialysis (Hemodialysis)
4.	Fluid Therapy (Oral Rehydration Therapy)
5.	Adrenalectomy

blog comments powered by Disqus

TREATMENT OPTIONS
for Hypertension,
Ranking and Evidence

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. Analytic charts allow you and your physicians to see at a glance the treatment options—including new, promising, off-label and experimental.

Free Updates for 1 Year
All 4514 Outcomes
Top 200 Key Drugs and Biologics
Top 50 Key Therapies and Procedures
Detailed History Charts
Full Research Evidence References
Sample PDF Report on Psoriasis >>

Price:

$24.95 USD & Delivery via PDF download
updates for 1 year

Research Interface PRO

Rapidly retrieve clinical outcome summaries for all evidence of drug efficacy against any disease in seconds. Click "Charts" to view graphs of relative efficacy of all drugs against any known disease. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time. Save hours of search and analysis time:

Two-clicks from Disease to Drug to Evidence: Drill down to full abstract
Enable Experts: Quickly identify key researchers and their publications
Enable FDA Link Generic: Two-clicks to FDA Products/Patents/Generics
Enable Export: All outcome statements and scores exportable to Excel/TSV for automated meta-analysis
Research Network: Explore drug and disease relationships visually
Enable Mobile Interface: Access from your cellphone, iPhone or PDA

Price:

$490.00 USD access via web interface
1 year subscription

Request Bulk Institution License Details >>